UniProt/SwissProt ID: | TTF2_HUMAN |
Description: | transcription termination factor, RNA polymerase II [Source:HGNC Symbol;Acc:12398] |
Location: | chr1 p13.1 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
T349 | GREAAtSSDDE | PhosphoSitePlus | |
S399 | KVSPAsGVSKK | PhosphoSitePlus | |
S520 | TAGGSsQCYRG | PhosphoSitePlus | |
T465 | SPEQGtNEKSN | HPRD | |
S251 | DVQREsEPLRE | PhosphoSitePlus; HPRD | |
Y30 | KGKSFyVCRAD | zf-GRF | PhosphoSitePlus |
S908 | SEAADsPRSST | SNF2_N | PhosphoSitePlus |
S810 | GGERLsILTKS | SNF2_N | PhosphoSitePlus |
S350 | REAATsSDDEE | PhosphoSitePlus | |
S217 | HKRDFsEIKSQ | PhosphoSitePlus | |
S351 | EAATSsDDEEE | PhosphoSitePlus | |
S396 | VQRKVsPASGV | PhosphoSitePlus; HPRD | |
S368 | SSKPGsPLLFD | PhosphoSitePlus; HPRD | |
T813 | RLSILtKSLLL | SNF2_N | PhosphoSitePlus |
Y416 | VARRVyLTTQL | PhosphoSitePlus | |
Y1036 | KHGLTyATIDG | Helicase_C | PhosphoSitePlus |
S460 | SGLTLsPEQGT | PhosphoSitePlus; HPRD; phosphoELM; SysPTM | |
T500 | LPRRGtQPVGS | PhosphoSitePlus; HPRD | |
T286 | LNKEYtNWEAK | PhosphoSitePlus | |
S810 | GGERLsILTKS | HPRD | |
Y285 | PLNKEyTNWEA | PhosphoSitePlus | |
S883 | NQSGRsPNNPF | SNF2_N | PhosphoSitePlus; SysPTM |
S402 | PASGVsKKVEP | PhosphoSitePlus; HPRD | |
S374 | PLLFDsTLDLE | HPRD | |
Y523 | GSSQCyRGHTN | PhosphoSitePlus | |
S221 | FSEIKsQQCQG | PhosphoSitePlus | |
T1019 | IVSQWtNMLKV | PhosphoSitePlus | |
T380 | TLDLEtKENLQ | PhosphoSitePlus; HPRD | |
S883 | NQSGRsPNNPF | HPRD; phosphoELM; SysPTM | |
S908 | SEAADsPRSST | HPRD | |
Dephosphorylation site |
TTF2_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000358478 | E623Q | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000358478 | L958F | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000358478 | D373Y | COSMIC | Hepatocellular Carcinoma | 21822264 |
ENSP00000358478 | P299S | COSMIC | Skin Cancer | 21984974 |
ENSP00000358478 | L958F | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000358478 | L436F | BIOMART | Breast Cancer | 21930507, 21930502 |
Differential expressed protein |
TTF2_HUMAN is not differential expressed protein. |
Hyperphosphorylation site |
TTF2_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
KPCA_HUMAN | TTF2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
TGFR2_HUMAN | TTF2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
Function Annotation |
KEGG Pathway |
TTF2_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0006355 | regulation of transcription, DNA-dependent | IEA | biological_process |
GO:0008023 | transcription elongation factor complex | TAS | cellular_component |
GO:0003677 | DNA binding | IEA | molecular_function |
GO:0008270 | zinc ion binding | IEA | molecular_function |
GO:0006397 | mRNA processing | IEA | biological_process |
GO:0003676 | nucleic acid binding | IEA | molecular_function |
GO:0006353 | DNA-dependent transcription, termination | TAS | biological_process |
GO:0005737 | cytoplasm | IDA | cellular_component |
GO:0005681 | spliceosomal complex | IEA | cellular_component |
GO:0008094 | DNA-dependent ATPase activity | TAS | molecular_function |
GO:0005524 | ATP binding | IEA | molecular_function |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0004386 | helicase activity | IEA | molecular_function |
GO:0016787 | hydrolase activity | IEA | molecular_function |
GO:0008026 | ATP-dependent helicase activity | IEA | molecular_function |
GO:0008380 | RNA splicing | IEA | biological_process |
GO:0006369 | termination of RNA polymerase II transcription | TAS | biological_process |
GO:0005634 | nucleus | IDA | cellular_component |